Literature DB >> 22493555

Notch3 regulates the activation of hepatic stellate cells.

Yi-Xiong Chen1, Zhi-Hong Weng, Shu-Ling Zhang.   

Abstract

AIM: To investigate whether Notch signaling is involved in liver fibrosis by regulating the activation of hepatic stellate cells (HSCs).
METHODS: Immunohistochemistry was used to detect the expression of Notch3 in fibrotic liver tissues of patients with chronic active hepatitis. The expression of Notch3 in HSC-T6 cells treated or not with transforming growth factor (TGF)-β1 was analyzed by immunofluorescence staining. The expression of Notch3 and myofibroblastic marker α-smooth muscle actin (α-SMA) and collagen I in HSC-T6 cells transfected with pcDNA3.1-N3ICD or control vector were detected by Western blotting and immunofluorescence staining. Moreover, effects of Notch3 knockdown in HSC-T6 by Notch3 siRNA were investigated by Western blotting and immunofluorescence staining.
RESULTS: The expression of Notch3 was significantly up-regulated in fibrotic liver tissues of patients with chronic active hepatitis, but not detected in normal liver tissues. Active Notch signaling was found in HSC-T6 cells. TGF-β1 treatment led to up-regulation of Notch3 expression in HSC-T6 cells, and over-expression of Notch3 increased the expression of α-SMA and collagen I in HSC-T6 without TGF-β1 treatment. Interestingly, transient knockdown of Notch3 decreased the expression of myofibroblastic marker and antagonized TGF-β1-induced expression of α-SMA and collagen I in HSC-T6.
CONCLUSION: Notch3 may regulate the activation of HSCs, and the selective interruption of Notch3 may provide an anti-fibrotic strategy in hepatic fibrosis.

Entities:  

Keywords:  Hepatic stellate cells; Liver fibrosis; Myofibroblast; Notch signaling; siRNA

Mesh:

Substances:

Year:  2012        PMID: 22493555      PMCID: PMC3319968          DOI: 10.3748/wjg.v18.i12.1397

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  24 in total

1.  Evaluation of selective gamma-secretase inhibitor PF-03084014 for its antitumor efficacy and gastrointestinal safety to guide optimal clinical trial design.

Authors:  Ping Wei; Marlena Walls; Ming Qiu; Richard Ding; Robert H Denlinger; Anthony Wong; Kosta Tsaparikos; Jitesh P Jani; Natilie Hosea; Michelle Sands; Sophia Randolph; Tod Smeal
Journal:  Mol Cancer Ther       Date:  2010-06-08       Impact factor: 6.261

Review 2.  Pathogenesis of liver fibrosis.

Authors:  Virginia Hernandez-Gea; Scott L Friedman
Journal:  Annu Rev Pathol       Date:  2011       Impact factor: 23.472

3.  Epithelial Notch signaling regulates interstitial fibrosis development in the kidneys of mice and humans.

Authors:  Bernhard Bielesz; Yasemin Sirin; Han Si; Thiruvur Niranjan; Antje Gruenwald; Seonho Ahn; Hideki Kato; James Pullman; Manfred Gessler; Volker H Haase; Katalin Susztak
Journal:  J Clin Invest       Date:  2010-10-18       Impact factor: 14.808

4.  Targeting ADAM-17/notch signaling abrogates the development of systemic sclerosis in a murine model.

Authors:  Niloufar Kavian; Amélie Servettaz; Céline Mongaret; Andrew Wang; Carole Nicco; Christiane Chéreau; Philippe Grange; Vincent Vuiblet; Philippe Birembaut; Marie-Danièle Diebold; Bernard Weill; Nicolas Dupin; Frédéric Batteux
Journal:  Arthritis Rheum       Date:  2010-11

5.  Inhibition of Notch signaling prevents experimental fibrosis and induces regression of established fibrosis.

Authors:  Clara Dees; Pawel Zerr; Michal Tomcik; Christian Beyer; Angelika Horn; Alfiya Akhmetshina; Katrin Palumbo; Nicole Reich; Jochen Zwerina; Michael Sticherling; Mark P Mattson; Oliver Distler; Georg Schett; Jörg H W Distler
Journal:  Arthritis Rheum       Date:  2011-05

6.  Jagged/Notch signalling is required for a subset of TGFβ1 responses in human kidney epithelial cells.

Authors:  Kristine C Nyhan; Noel Faherty; Gregg Murray; Laurence Berubé Cooey; Catherine Godson; John K Crean; Derek P Brazil
Journal:  Biochim Biophys Acta       Date:  2010-09-15

7.  Preventive effect of Notch signaling inhibition by a gamma-secretase inhibitor on peritoneal dialysis fluid-induced peritoneal fibrosis in rats.

Authors:  Fengxin Zhu; Tang Li; Fanghua Qiu; Jinjin Fan; Qin Zhou; Xuebing Ding; Jing Nie; Xueqing Yu
Journal:  Am J Pathol       Date:  2010-01-07       Impact factor: 4.307

8.  Notch1 signaling in FIZZ1 induction of myofibroblast differentiation.

Authors:  Tianju Liu; Biao Hu; Yoon Young Choi; Myoungja Chung; Matthew Ullenbruch; Hongfeng Yu; John B Lowe; Sem H Phan
Journal:  Am J Pathol       Date:  2009-04-06       Impact factor: 4.307

Review 9.  Rational targeting of Notch signaling in cancer.

Authors:  P Rizzo; C Osipo; K Foreman; T Golde; B Osborne; L Miele
Journal:  Oncogene       Date:  2008-09-01       Impact factor: 9.867

Review 10.  Notch inhibitors as a new tool in the war on cancer: a pathway to watch.

Authors:  Benjamin Purow
Journal:  Curr Pharm Biotechnol       Date:  2009-02       Impact factor: 2.837

View more
  23 in total

1.  Inhibition of Mastermind-like 1 alleviates liver fibrosis induced by carbon tetrachloride in rats.

Authors:  Shaoping Zheng; Yixiong Chen; Shaojiang Zheng; Zhihui He; Zhihong Weng
Journal:  Exp Biol Med (Maywood)       Date:  2018-11-06

Review 2.  Notch in fibrosis and as a target of anti-fibrotic therapy.

Authors:  Biao Hu; Sem H Phan
Journal:  Pharmacol Res       Date:  2016-04-21       Impact factor: 7.658

3.  Hes1, an important gene for activation of hepatic stellate cells, is regulated by Notch1 and TGF-β/BMP signaling.

Authors:  Kai Zhang; Yan-Qiong Zhang; Wen-Bing Ai; Qing-Ting Hu; Qiao-Juan Zhang; Lin-Yan Wan; Xiao-Lian Wang; Chang-Bai Liu; Jiang-Feng Wu
Journal:  World J Gastroenterol       Date:  2015-01-21       Impact factor: 5.742

4.  Oncogenic role of the Notch pathway in primary liver cancer.

Authors:  Jie Lu; Yujing Xia; Kan Chen; Yuanyuan Zheng; Jianrong Wang; Wenxia Lu; Qin Yin; Fan Wang; Yingqun Zhou; Chuanyong Guo
Journal:  Oncol Lett       Date:  2016-05-18       Impact factor: 2.967

5.  Cross-talk between Notch and Hedgehog regulates hepatic stellate cell fate in mice.

Authors:  Guanhua Xie; Gamze Karaca; Marzena Swiderska-Syn; Gregory A Michelotti; Leandi Krüger; Yuping Chen; Richard T Premont; Steve S Choi; Anna Mae Diehl
Journal:  Hepatology       Date:  2013-09-30       Impact factor: 17.425

Review 6.  Maladaptive regeneration - the reawakening of developmental pathways in NASH and fibrosis.

Authors:  Changyu Zhu; Ira Tabas; Robert F Schwabe; Utpal B Pajvani
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-10-13       Impact factor: 46.802

7.  MicroRNA-489-3p Represses Hepatic Stellate Cells Activation by Negatively Regulating the JAG1/Notch3 Signaling Pathway.

Authors:  Juanjuan Li; Shouquan Dong; Mingliang Ye; Ganjing Peng; Jie Luo; Chun Wang; Jing Wang; Qiu Zhao; Ying Chang; Hongling Wang
Journal:  Dig Dis Sci       Date:  2020-03-07       Impact factor: 3.199

Review 8.  Myofibroblasts.

Authors:  Biao Hu; Sem H Phan
Journal:  Curr Opin Rheumatol       Date:  2013-01       Impact factor: 5.006

9.  Costunolide represses hepatic fibrosis through WW domain-containing protein 2-mediated Notch3 degradation.

Authors:  Mao-Xu Ge; Hong-Tao Liu; Na Zhang; Wei-Xiao Niu; Zhen-Ning Lu; Yun-Yang Bao; Rui Huang; Dong-Ke Yu; Rong-Guang Shao; Hong-Wei He
Journal:  Br J Pharmacol       Date:  2019-12-23       Impact factor: 8.739

10.  Inhibition of Notch signaling by a γ-secretase inhibitor attenuates hepatic fibrosis in rats.

Authors:  Yixiong Chen; Shaoping Zheng; Dan Qi; Shaojiang Zheng; Junli Guo; Shuling Zhang; Zhihong Weng
Journal:  PLoS One       Date:  2012-10-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.